The role of the implantable cardiac defibrillator in the management

Olaf Hedrich; Gianfranco Buja; Domenico Corrado; Mark S. Link; Thomas Wichter; N. A Mark Estes

doi:10.1007/978-88-470-0490-0_21

The role of the implantable cardiac defibrillator in the management

Olaf Hedrich, Gianfranco Buja, Domenico Corrado, Mark S. Link, Thomas Wichter, N. A Mark Estes

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The management of patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) has evolved considerably over the last several years. Because many patients with ARVC/D may be at risk for sudden cardiac death (SCD) and clinical series have reported favorable outcomes with this therapy, the implantable cardioverter-defibrillator (ICD) has assumed a larger role in therapy. On the basis of collective observations from several series of patients, implantation of an ICD in a patient with ARVC/D has a major impact on decreasing the risk of SCD. This chapter examines the available clinical information regarding ICD therapy in patients with ARVC/D.

Original language	English (US)
Title of host publication	Arrhythmogenic RV Cardiomyopathy/Dysplasia
Subtitle of host publication	Recent Advances
Publisher	Springer Milan
Pages	189-197
Number of pages	9
ISBN (Print)	9788847004894
DOIs	https://doi.org/10.1007/978-88-470-0490-0_21
State	Published - Dec 1 2007

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-88-470-0490-0_21

Cite this

@inbook{d7c7bbb1dd644713b238299a78a79e4e,

title = "The role of the implantable cardiac defibrillator in the management",

abstract = "The management of patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) has evolved considerably over the last several years. Because many patients with ARVC/D may be at risk for sudden cardiac death (SCD) and clinical series have reported favorable outcomes with this therapy, the implantable cardioverter-defibrillator (ICD) has assumed a larger role in therapy. On the basis of collective observations from several series of patients, implantation of an ICD in a patient with ARVC/D has a major impact on decreasing the risk of SCD. This chapter examines the available clinical information regarding ICD therapy in patients with ARVC/D.",

author = "Olaf Hedrich and Gianfranco Buja and Domenico Corrado and Link, {Mark S.} and Thomas Wichter and Estes, {N. A Mark}",

year = "2007",

month = dec,

day = "1",

doi = "10.1007/978-88-470-0490-0_21",

language = "English (US)",

isbn = "9788847004894",

pages = "189--197",

booktitle = "Arrhythmogenic RV Cardiomyopathy/Dysplasia",

publisher = "Springer Milan",

}

TY - CHAP

T1 - The role of the implantable cardiac defibrillator in the management

AU - Hedrich, Olaf

AU - Buja, Gianfranco

AU - Corrado, Domenico

AU - Link, Mark S.

AU - Wichter, Thomas

AU - Estes, N. A Mark

PY - 2007/12/1

Y1 - 2007/12/1

N2 - The management of patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) has evolved considerably over the last several years. Because many patients with ARVC/D may be at risk for sudden cardiac death (SCD) and clinical series have reported favorable outcomes with this therapy, the implantable cardioverter-defibrillator (ICD) has assumed a larger role in therapy. On the basis of collective observations from several series of patients, implantation of an ICD in a patient with ARVC/D has a major impact on decreasing the risk of SCD. This chapter examines the available clinical information regarding ICD therapy in patients with ARVC/D.

AB - The management of patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) has evolved considerably over the last several years. Because many patients with ARVC/D may be at risk for sudden cardiac death (SCD) and clinical series have reported favorable outcomes with this therapy, the implantable cardioverter-defibrillator (ICD) has assumed a larger role in therapy. On the basis of collective observations from several series of patients, implantation of an ICD in a patient with ARVC/D has a major impact on decreasing the risk of SCD. This chapter examines the available clinical information regarding ICD therapy in patients with ARVC/D.

UR - http://www.scopus.com/inward/record.url?scp=84895227474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895227474&partnerID=8YFLogxK

U2 - 10.1007/978-88-470-0490-0_21

DO - 10.1007/978-88-470-0490-0_21

M3 - Chapter

AN - SCOPUS:84895227474

SN - 9788847004894

SP - 189

EP - 197

BT - Arrhythmogenic RV Cardiomyopathy/Dysplasia

PB - Springer Milan

ER -

The role of the implantable cardiac defibrillator in the management

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this